Effect of Socioeconomic Factors and Family History on the Incidence of Diabetes in an Adult Diabetic Population from Algeria
,
Abstract
Background: Diabetes mellitus is a serious public health problem worldwide and particularly in developing countries. In Algeria, this metabolic disorder occurs with a wide variety or atypical forms that linked to multiple risk factors including local habits and traditions. This study aimed to determine the impact of risk factors (metabolic syndrome, social, cultural, physical activity, family history and the treatment used) on the incidence of diabetes.
Methods: This cross-sectional study was conducted in 2013 on a random sample from a resident population in Tebessa, Northeast Algeria, which underwent a significant expanding of diabetes prevalence conditioned by profound socio-economic changes. The survey included 200 subjects, randomly selected; with 100 controls and 100 diabetic patients, (26 diabetic subjects with type 1 diabetes mellitus ‘T1DM’ and 74 subjects with type two diabetes mellitus ‘T2DM’).
Results: Diabetic subjects were significantly affected by all these risk factors, including metabolic syndrome that was higher in women. The most common treatment among surveyed T1DM subjects was insulin, whereas T2DM patients used metformin. In addition, the duration from T1DM onset in the surveyed subjects is older than T2DM onset. The incidence of diabetes is significantly in close relationship between the majorities of these factors of risk.
Conclusion: Subjects with a high socioeconomic status can afford a healthier way of life to avoid the risk of developing diabetes compared to subjects with lower social level.
Amos AF, McCarty DJ, Zimmet P (1997). The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med, 14(Suppl 5):S1–85.
Zimmet P, Alberti KGMM, Shaw J (2001). Global and societal implications of the diabetes epidemic. Nature, 414(6865):782-7.
Venkat Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F (2000). Diabetes—a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract, 50(Suppl 2): S77–84.
Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5): 1047–1053.
Zaoui S, Biémont C, Meguenni K (2007). Epidemiology of diabetes in urban and rural regions of Tlemcen (Western Algeria). Sante, 17(1): 15–21.
King H, Aubert RE, Herman WH (1998). Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care, 21(9): 1414–31.
WHO (2005). Mesure des facteurs de risque des maladies non transmissibles dans deux villages pilotes en Algérie, approche STEP wise de l’OMS. http://www.who.int/chp/steps/2007_STEPS_Report_Niger.pdf.
Benotmane A, Mohammedi F, Ayad F, Kadi K, Azzouz A (2000). Diabetic foot lesions: etiologic and prognostic factors. Diabetes Metab, 26(2): 113–7.
Dali-Sahi M, Benmansour D, Aouar A, Karam N (2012). Étude de l’épidémiologie du diabète de Type 2 dans des populations endogames de l’ouest algérien. Leban Sci J, 13(2): 17–26.
National Diabetes Data Group (1979). Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28(12): 1039–1057.
Dowse GK, Zimmet PZ, Collins VR (1996). Insulin levels and the natural history of glucose intolerance in Nauruans. Diabetes, 45(10): 1367–1372.
Khélifi N, Falfoul A, AmroucheC, Temessek A, Gammoudi A, Jammoussi H, Lahmer I, Blouza S (2011). Fréquence et caractéristiques du syndrome métabolique chez le diabétique âgé. J Diabetes Metab, 37: 83.
Beck-Nielsen H, Groop LC (1994). Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest, 94: 1714–1721.
Vionnet N (2000). Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2 diabetes locus on chromosome 1q21-q24. Am J Hum Genet, 67: 1470–1480.
Ramachandran A, Snehalatha C, Viswanathan V, Viswanathan M, Haffner SM (1997). Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabetes Res Clin Pract, 36(2): 121–125.
Elhadd TA, Al-Amoudi AA, Alzahrani AS (2007). Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: a review. Ann Saudi Med, 27(4): 241–250.
Sumner AE (2008). The relationship of body fat to metabolic disease: influence of sex and ethnicity. Gend Med, 5(4): 361–371.
Ferdi NEH, Abla K, Chenchouni H (2016). Biochemical profile of an adult diabetic population from Algeria in relation with anthropometric parameters, age, and gender. (Under review).
Ross NA, Gilmour H, Dasgupta K (2010). Incidence du diabète sur 14 années: le rôle du statut socioéconomique. Rapp Santé, 21(3): 21–30.
Bonnet F, Laville M (2005). Le syndrome métabolique : définition, épidémiologie, Complications. Spectra Biol, 145: 27–29.
Ford ES, Giles WH, Dietz WH (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 287: 356–359.
Diallo TS (2010). Syndrome Métabolique et Diabète en Guinée. Diabetes Metab, 36: 101.
Dalichampt M, Fosse S, Fagot-Campagna A (2008). O96 Prévalence du diabète et relations avec les caractéristiques socioéconomiques et le pays d’origine, selon l’enquête décennale Santé 2002–2003. Diabetes Metab, 34: H40.
Fosse S, Dalichampt M, Fagot-Campagna A (2011). Prévalence du diabète et recours aux soins en fonction du niveau socio-économique et du pays d'origine en France métropolitaine: enquête décennale santé 2002–2003 et enquête santé et protection sociale 2002 et 2004. http://opac.invs.sante.fr/doc_num.php?explnum_id=7620.
Fan L, Sidani S (2009). Effectiveness of diabetes self-management education intervention elements: a meta-analysis. Can J Diabetes, 33(1): 18–26.
Monnier L (2010). Diabétologie. Elsevier Health Sciences. Italy.
Almind K, Doria A, Kahn CR (2001). Putting the genes for type II diabetes on the map. Nature Med, 7(3): 277–279.
Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Froguel P, et al. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445(7130): 881–885.
Fagot-Campagna A, Romon I, Fosse S, Roudier C (2010). Prévalence et incidence du diabète, et mortalité liée au diabète en France. Synthèse épidémiologique. http://opac.invs.sante.fr/doc_num.php?explnum_id=102.
Ajdi F, Agerd L, Salhi H, Safi S (2010). P241 Étude le profil lipidique chez le diabétique type 2. Diabetes Metab, 36: A95–A96.
Louda F, Addi H, Hallab L, Chadli A, Elghomari H, Farouqi A (2010). P60 Hypertension artérielle et diabète de type 2. Diabetes Metab, 36: A53–A54.
Moussa Balde N, Samah Bangoura J, Kouyaté M, Bah S, Camara E, Pounthioun Diallo I, Pathé Diallo M (2012). P95 Retard de croissance et retard pubertaire chez les enfants diabétiques en Guinée. Diabetes Metab, 38: A54.
Benharrats K, Hamdaoui F, Bachaoui M, Aribi S, Cherrak A, Belhadj M (2012). P97 Profil clinique et métabolique des diabétiques de type 1 vus en hôpital de jour. Diabetes Metab, 38: A54–A55.
Ben Ahmed I, Kassem A, Jamoussi H, Amrouche C, Blouza-Chabchoub S (2008). Qualité de vie des diabétiques tunisiens insulinotraités. Diabetes Metab, 34: H85.
Cersosimo E, Cervera A, Wajcberg E, Triplitt C, Fernandez M, Zuo P, de Fronzo (2008). Mode d’action de l’exénatide sur la réduction des glycémies post-prandiales dans le diabète de type 2. Diabetes Metab, 34: H9.
Pouchain D, Lebeau JP, Berkhout C, Le Reste JY, Moreau A, Wilmart F (2010). Les objectifs préconisés dans la recommandation française sur le traitement médicamenteux du diabète de type 2 sont-ils encore d’actualité? Exercer, 94: 145–54.
Beaudeux JL, Durand G (2008). Biochimie médicale (marqueurs actuels et perspectives). 2ème édition. Lavoisier. Paris. France.
Idelman S, Verdetti J (2000). Endocrinologie et communications cellulaires. Collection Grenoble sciences, France.
Sachon C, Grimaldi A, Heurtier A (2010). Complications du diabète. Encyclopédie Pratique de Médecine. 3(0850): 1–7.
Fery F, Paquot N (2005). Etiopathogénie et physiopathologie du diabète de type 2. Rev Med Liege, 60(5–6): 361–368.
Kahn S E, Hull RL, Utzschneider KM (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444(7121): 840–846.
Guénette LA, Parent G, Dionne JY (2013). Produits de santé naturels et médicaments. Curr Opin Lipidol, 19(1): 1.
Guillausseau P (2007). Sulfamides hypoglycémiants et apparentés et leur utilisation. Presse Med, 36: 1.
Imounachen MZ (2010). Antidiabétiques oraux. L’officinal, 81: 34–36.
Drouin P, Blickle J, Charbonnel B, Eschwege E, Guillausseau P, Plouin P, Sauvanet J (1999). Diagnosis and classification of diabetes mellitus: the new criteria. Diabetes Metab, 25: 72–83.
Graillot D, Quipourt V, Bouillet B, Petit JM, Manckoundia P (2012). Type 2 diabetes in the elderly, which specific features? Rev Med Interne, 33(10): 575–579.
Helmrich SP, Ragland DR, Leung RW, Paffenbarger Jr RS (1991). Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. New Engl J Med, 325(3): 147–152.
Sachon C, Grimaldi A, Masseboeuf N, Corset E (2009). Diabète non insulinodépendant. Encycl Prat Med, 3 (0810): 1–5.
| Files | ||
| Issue | Vol 45 No 12 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Diabetes Type 1 diabetes mellitus Type 2 diabetes mellitus Risk factors Diabetes treatments Algeria | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
